Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R,. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012;64(1):285-296.

Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML. Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison. J Intern Med. 2012;271(3):247-256.

Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time. Curr Med Res Opin. 2012;28(6):891-899.

Peters SAE, Palmer MK, den Ruijter HM, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Sample size requirements in trials using repeated measurements and the impact of trial design. Curr Med Res Opin. 2012;28(5):681-688.

Peters SAE, Bots ML, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Moons KG, Koffijberg H. Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models. J Clin Epidemiol. 2012;65(6):686-695.

Barzilay JI, Howard AG, Evans GW, Fleg JL, Cohen RM, Booth GL, Kimel AR, Pedley CF, Cushman WC. Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Diabetes Care. 2012;35(7):1401-1405.

Peters SAE, Lind L, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen J, Bots ML, den Ruijter HM. Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study. J Intern Med. 2012;272(3):257-266.

Ardoin SP, Evans G, Sandborg C, Barnhart HX, Schanberg LE. A clinically relevant benefit of statins in young patients with [reply to letter]. Arthritis Rheum. 2012;64(8):2805-2806.

Den Ruijter HM, Peters SAE, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW,. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012;308(8):796-803.

Lind L, Peters SAE, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. J Am Soc Echocardiogr. 2012;25(10):1120-1127.

Getaneh A, Light LS, Brillon DJ, Calles Escandon J, Felicetta J, Evans GW, Lopez-Jimenez CR, Cuddihy R, Bigger JT. Diabetes control among Hispanics in the Action to Control Cardiovascular Risk in Diabetes trial. J Gen Intern Med. 2012;27(11):1499-1505.

Peters SAE, Palmer MK, Grobbee DE, Crouse JR III, Evans GW, Raichlen JS, Bots ML. Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study. J Hypertens. 2011;29(6):1145-1154.

Dogan S, Plantinga Y, Crouse JR III, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect. J Hypertens. 2011;29(11):2181-2193.

Peters SAE, Dogan S, Meijer R, Palmer MK, Grobbee DE, Crouse JR III, O'Leary DH, Evans GW, Raichlen JS, Bots ML. The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study. J Atheroscler Thromb. 2011;18(9):784-795.

Crouse JR III, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study. Eur J Cardiovasc Prev Rehabil. 2010;17(2):223-229.

Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.

Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJP, Shear CL, Evans GW, Visseren FL, Bots ML. Completeness of carotid intima media thickness measurements depends on body composition: the RADIANCE 1 and 2 trials. J Atheroscler Thromb. 2010;17(5):526-535.

Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578-1584.

LaRose A, Danhauer SC, Feldman J, Evans GW, Kemper KJ. Brief stress-reduction training in an academic health center [letter]. J Altern Complement Med. 2010;16(9):935-936.

Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJP, Shear CL, Evans GW, Visseren FL, Bots ML. Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann Med. 2010;42(6):447-464.

Meijer R, Stork S, Evans GW, Grobbee DE, Bots ML. Striking increases in carotid artery wall thickness in healthy subjects. Cerebrovasc Dis. 2010;30(5):448-455.

Buxbaum SG, Ekunwe L, Fox ER, Evans G, Sarpong DF. Linkage analysis of carotid intima-media thickness in the Jackson Heart Study [abstract]. Genet Epidemiol. 2010;34(8):959.

Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML. Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study. Curr Med Res Opin. 2009;25(1):109-122.

Nagarajarao HS, Taylor HA, Lee JH, Benjamin EJ, Agrawal K, Evans G, Fox ER. The relation of C-reactive protein to carotid intima-media thickness in African Americans: the Jackson Heart Study [abstract]. Circulation. 2009;119(10):e315.

Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR III. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. J Intern Med. 2009;265(6):698-707.

Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009;60(5):1496-1507.

Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52(11):2288-2298.

Bots M, Palmer M, Grobbee D, Crouse J, O'Leary D, Evans G, Raichlen J. C-reactive protein lowering with rosuvastatin in the METEOR study [abstract]. Atheroscler Suppl. 2009;10(2):Abstr P952.

Dogan S, Meijer R, Grobee D, Crouse J, O'Leary D, Evans G, Raichlen J, Palmer M, Bots M. Assessment of carotid plaque progression with ultrasound in a low-risk population [abstract]. Atheroscler Suppl. 2009;10(2):Abstr P953.

Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, et al. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the Rating Atherosclerotic Disease Change by Imaging with a New CETP Inhibitor (RADIANCE) Trials. Circulation. 2008;118(24):2515-2522.

Evans GW, Palmer MK, O'Leary DH, Crouse JR III, Bots ML, Grobbee DE, Raichlen JS. Design of carotid intima-media thickness trials [abstract]. Circulation. 2008;118(18 Suppl 2):S760.

Eigenbrodt ML, Sukhija R, Rose KM, Tracy RE, Couper DJ, Evans GW, Bursac Z, Mehta JL. Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study [online only]. Cardiovasc Ultrasound. 2007;5():article 11.

Crouse JR III, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA. 2007;297(12):1344-1353.

Crouse JR III, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS. Rosuvastatin arrests progression of carotid intima media thickness in low-risk individuals: main results of the METEOR study [abstract]. J Am Coll Cardiol. 2007;49(9 Suppl I):392A-393A.

Carr JJ, Person S, Sidney S, Evans G, Colangelo L, Jacobs D, Liu K, Lewis CE, Schreiner P, Loria C, et al. Coronary artery calcified plaque in individuals 38 to 50 years old and cardiovascular risk factors measured 5 years earlier: the Coronary Artery Risk Development in Young Adults (CARDIA) study [abstract]. Circulation. 2007;115(8):e217.

Crouse JR III, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study [abstract]. Curr Med Res Opin. 2007;23(3):641-648.

Kastelein JJP, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007;356(16):1620-1630.

Kastelein JJP, van Leuven SI, Evans GW, Riley WA, Revkin JH, Shear CL, Bots ML. Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis. Curr Med Res Opin. 2007;23(4):885-894.

Bots ML. Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet. 2007;370(9582):153-160.

Cushman WC, Grimm RH Jr, Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A, Basile JN. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12A Suppl):44i-55i.

Bots ML, Raichlen JS, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Crouse JR. Rosuvastatin reduces progression of carotid atherosclerosis within 12 months of treatment: the METEOR trial [abstract]. Circulation. 2007;116(16 Suppl):17.

Evans GW, Raichlen JS, Bots ML, Palmer MK, O'Leary DH, Grobbee DE, Crouse JR. Rosuvastatin treatment in carotid atherosclerosis: effect of Framingham risk factors and baseline intima-media thickness in the METEOR trial [abstract]. Circulation. 2007;116(16 Suppl):848.

Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the Atherosclerosis Risk in Communities Study. Hypertension. 2006;48(6):1037-1042.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

WFBMC
All

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Department of Biostatistics

Quick Reference

Request an Appointment

New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.

Find a Doctor Ways to Give